The winner of the Non-Coding RNA 2018 Travel Award Dr. Cristian Rodriguez-Aguayo at TAT 2018

Dr. Cristian Rodriguez-Aguayo (University of Texas MD Anderson Cancer Center, Houston, TX), who was awarded the Non-Coding RNA Travel Award, attended the Targeted Anticancer Therapies (TAT) 2018 meeting held in Paris (France) between 5th and 7th March.

The Targeted Anticancer Therapies (TAT) congress is considered one of the most prominent congresses in the field and a premier forum for the discussion of early phase drug development and translational research. The congress provides an important venue for discussions shaping the most promising paths for the development of new therapeutics and offers an opportunity to shape future of drug development together with the world’s most renowned experts.

Dr. Cristian Rodriguez-Aguayo’s research focuses on the understanding of the functional basis and biological mechanisms in which RBPs and non-coding RNAs promote cancer growth and tumor progression. At this meeting, Dr. Rodriguez-Aguayo showed his findings in a poster presentation entitled “Regulation of hnRNPA1 by microRNAs controls the miR-18a–KRAS axis in chemotherapy-resistant ovarian cancer”.